Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2013
Melanoma, version 2.2013: featured updates to the NCCN guidelinesDaniel G Coit, Robert Andtbacka, Christopher J Anker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyDaniel G Coit, John A Thompson, Mark R Albertini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Melanoma, version 4.2014Daniel G Coit, John A Thompson, Robert Andtbacka, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyDaniel G Coit, John A Thompson, Alain Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016Daniel G Coit, John A Thompson, Alain Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019P Kumar Rao, Christopher Barker, Daniel G Coit, et al.
Nature Medicine|August 26, 2025
Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Nature Cancer|January 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Nature Medicine|August 14, 2025
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Cell Reports|January 14, 2023
Single-cell RNA sequencing identifies a population of human liver-type ILC1sBenjamin Krämer, Ansel P Nalin, Feiyang Ma, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2013
Melanoma, version 2.2013: featured updates to the NCCN guidelinesDaniel G Coit, Robert Andtbacka, Christopher J Anker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyDaniel G Coit, John A Thompson, Mark R Albertini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Melanoma, version 4.2014Daniel G Coit, John A Thompson, Robert Andtbacka, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyDaniel G Coit, John A Thompson, Alain Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016Daniel G Coit, John A Thompson, Alain Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019P Kumar Rao, Christopher Barker, Daniel G Coit, et al.
Nature Medicine|August 26, 2025
Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Nature Cancer|January 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Nature Medicine|August 14, 2025
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Cell Reports|January 14, 2023
Single-cell RNA sequencing identifies a population of human liver-type ILC1sBenjamin Krämer, Ansel P Nalin, Feiyang Ma, et al.
Pageof 28